David Redfern - Articles and news items

GlaxoSmithKline logo

GSK increases stake in Indian Pharmaceuticals subsidiary to 75 per cent after Open Offer

Industry news / 10 March 2014 / GlaxoSmithKline

GlaxoSmithKline plc announced that GSK has successfully increased its stake in its publicly-listed pharmaceuticals subsidiary in India (GlaxoSmithKline Pharmaceuticals Limited), from 50.7% to 75%…

GlaxoSmithKline logo

GSK initiates voluntary open offer to increase stake in its pharmaceuticals subsidiary in India

Industry news / 16 December 2013 / GlaxoSmithKline

GSK intends to keep the Company publicly-listed…

GlaxoSmithKline logo

GlaxoSmithKline reaches agreement with Aspen to divest thrombosis brands and related manufacturing site for £0.7 billion

Industry news / 30 September 2013 / GlaxoSmithKline

GlaxoSmithKline (LSE:GSK) today announced it has reached agreement to sell its thrombosis brands, Arixtra® and Fraxiparine®, and the Notre-Dame de Bondeville (NDB)…

GlaxoSmithKline logo

GSK increases stake in its publicly-listed Consumer Healthcare subsidiary in India to 72.5 per cent

Industry news, News / 5 February 2013 / GlaxoSmithKline

“We are very pleased with the outcome of this transaction…”

GlaxoSmithKline logo

GSK announces agreement in principle to increase its stake in GlaxoSmithKline Consumer Nigeria PLC

Industry news, News / 26 November 2012 / GlaxoSmithKline

GSK and GSK Nigeria have reached agreement…

GlaxoSmithKline logo

Shionogi and ViiV Healthcare announce new agreement to commercialise and develop integrase inhibitor portfolio

Industry news, News / 29 October 2012 / GlaxoSmithKline

ViiV Healthcare Ltd and Shionogi & Co., Ltd., have entered into an agreement…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...